Device Trial Radar · NCT06834880
AQT90 FLEX NTproBNP2 Test Kit - 23004 - Reference Interval Study
Last checked: Nov 19, 2026Latest source record: Aug 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
781
Actual
Start
Jan 27, 2025
Primary completion
Feb 5, 2025
Study completion Feb 5, 2025
Sponsor
- Lead sponsor
- Radiometer Medical ApSNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 19, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to establish the overall (age- and sex independent) at least 95th percentile upper reference limit (URL) of the NTproBNP2 Test Kit on the AQT90 FLEX analyzer.
Conditions
- Heart Failure
Interventions
No intervention; Observational studyDevice
Sample bank with Health Questionnaire
Primary outcomes
What the sponsor says the trial is designed to measure.
- 95th percentile of normal concentrations with 95% confidence intervals (CI) for overall samplesTime frame: Baseline
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Radiometer Turku Oy
Turku, Finland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.